نتایج جستجو برای: dalteparin

تعداد نتایج: 393  

Journal: :Advances in medical sciences 2009
A Rydzewska-Rosolowska J Borawski M Mysliwiec

PURPOSE Endostatin (ES) is a potent inhibitor of angiogenesis and neoangiogenesis, and interestingly its activity is modified by heparin. To understand if low-molecular weight heparins have different clinical profiles regarding this cytokine, we studied the effects of enoxaparin, nadroparin and dalteparin administered for hemodialysis (HD) anticoagulation on plasma ES levels. MATERIAL AND MET...

Journal: :Thrombosis and haemostasis 2007
Rupert M Bauersachs Joachim Dudenhausen Andree Faridi Thorsten Fischer Samson Fung Ulrich Geisen Job Harenberg Eberhard Herchenhan Franz Keller Bettina Kemkes-Matthes Helmut Schinzel Michael Spannagl Christian J Thaler

Women with a history of venous thromboembolism (VTE), thrombophilia or both may be at increased risk of thrombosis during pregnancy, but the optimal management strategy is not well defined in clinical guidelines because of limited trial data. A strategy of risk assessment and heparin prophylaxis was evaluated in pregnant women at increased risk of VTE. In a prospective trial (Efficacy of Thromb...

Journal: :Iranian journal of kidney diseases 2009
Amir Ahmad Nassiri Monir Sadat Hakemi Mehrdad Soulati Mehran Marashian Khosrow Rahbar Fereidoun Azizi

INTRODUCTION Dialysis-induced oxidative stress is one of the mechanisms of atherosclerotic changes. Heparin, used in hemodialysis, is an anticoagulant drug with anti-inflammatory and antioxidant effects. This study was planned in order to evaluate the antioxidant effects of heparin and dalteparin (low-molecular weight heparin). MATERIALS AND METHODS Twenty-two patients underwent 3 hemodialysi...

Journal: :Molecules 2017
Antonella Bisio Elena Urso Marco Guerrini Pauline de Wit Giangiacomo Torri Annamaria Naggi

A number of low molecular weight heparin (LMWH) products are available for clinical use and although all share a similar mechanism of action, they are classified as distinct drugs because of the different depolymerisation processes of the native heparin resulting in substantial pharmacokinetic and pharmacodynamics differences. While enoxaparin has been extensively investigated, little informati...

2013
Fereshteh Farajdokht Arezo Nahavandi Mansoureh Soleimani

Received: 3 March 2012 First Revision: 15 April 2012 Accepted: 20 June 2012

Journal: :Physical review. E, Statistical, nonlinear, and soft matter physics 2015
Fajun Yu

We present the nonautonomous discrete bright soliton solutions and their interactions in the discrete Ablowitz-Ladik (DAL) equation with variable coefficients, which possesses complicated wave propagation in time and differs from the usual bright soliton waves. The differential-difference similarity transformation allows us to relate the discrete bright soliton solutions of the inhomogeneous DA...

Journal: :JAMA 2014
Robert A Fowler Nicole Mittmann William Geerts Diane Heels-Ansdell Michael K Gould Gordon Guyatt Murray Krahn Simon Finfer Ruxandra Pinto Brian Chan Orges Ormanidhi Yaseen Arabi Ismael Qushmaq Marcelo G Rocha Peter Dodek Lauralyn McIntyre Richard Hall Niall D Ferguson Sangeeta Mehta John C Marshall Christopher James Doig John Muscedere Michael J Jacka James R Klinger Nicholas Vlahakis Neil Orford Ian Seppelt Yoanna K Skrobik Sachin Sud John F Cade Jamie Cooper Deborah Cook

IMPORTANCE Venous thromboembolism (VTE) is a common complication of acute illness, and its prevention is a ubiquitous aspect of inpatient care. A multicenter blinded, randomized trial compared the effectiveness of the most common pharmocoprevention strategies, unfractionated heparin (UFH) and the low-molecular-weight heparin (LMWH) dalteparin, finding no difference in the primary end point of l...

Journal: :BMC Nephrology 2004
Birgit Näsström Bernd Stegmayr Gunilla Olivecrona Thomas Olivecrona

BACKGROUND Lipoprotein lipase (LPL) has a central role in the catabolism of triglyceride-rich lipoproteins. The enzyme is anchored to the vascular endothelium through interaction with heparan sulphate proteoglycans and is displaced from this interaction by heparin. When heparin is infused, there is a peak of LPL activity accompanied by a reduction in triglycerides (TG) during the first hour, fo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید